FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+11.15%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$15.5B
AUM Growth
+$15.5B
(-5.3%)
Cap. Flow
-$1.98B
Cap. Flow
% of AUM
-12.82%
Top 10 Holdings %
Top 10 Hldgs %
30.95%
Holding
325
New
13
Increased
38
Reduced
38
Closed
79
Top Buys
| 1 |
Intuit
INTU
|
$351M |
| 2 |
Salesforce
CRM
|
$228M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$218M |
| 4 |
Alibaba
BABA
|
$194M |
| 5 |
S&P Global
SPGI
|
$120M |
Top Sells
| 1 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$497M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
$340M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
$296M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$294M |
| 5 |
Meta Platforms (Facebook)
META
|
$245M |
Sector Composition
| 1 | Healthcare | 35.55% |
| 2 | Technology | 20.53% |
| 3 | Financials | 15.86% |
| 4 | Industrials | 9.11% |
| 5 | Communication Services | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Blackstone
BX
$131B
| $241M | 1.42% |
3,248,951
+134,000
| +4% | +$9.94M |
|
27
Aon
AON
$80.6B
| $237M | 1.4% |
788,086
-20,400
| -3% | -$6.12M |
|
|
28
Alibaba
BABA
$325B
| $234M | 1.38% |
2,661,000
+2,197,000
| +473% | +$194M |
|
|
XYZ
29
Block, Inc.
XYZ
$46.2B
| $202M | 1.19% |
3,218,000
+634,000
| +25% | +$39.8M |
|
30
New York Times
NYT
$9.58B
| $197M | 1.16% |
6,068,791
-1,759,282
| -22% | -$57.1M |
|
31
United Therapeutics
UTHR
$17.7B
| $182M | 1.08% |
655,873
+106,200
| +19% | +$29.5M |
|
32
CoStar Group
CSGP
$37.2B
| $176M | 1.04% |
2,280,185
-680,000
| -23% | -$52.6M |
|
33
Exelixis
EXEL
$9.95B
| $174M | 1.03% |
10,868,149
+192,305
| +2% | +$3.08M |
|
|
VMW
34
DELISTED
VMware, Inc
VMW
| $171M | 1.01% |
1,390,623
+215,000
| +18% | +$26.4M |
|
35
Biogen
BIIB
$20.5B
| $164M | 0.97% |
592,699
+287,200
| +94% | +$79.5M |
|
36
AbbVie
ABBV
$374B
| $152M | 0.9% |
939,212
+214,100
| +30% | +$34.6M |
|
37
Humana
HUM
$37.5B
| $138M | 0.82% |
270,400
+19,200
| +8% | +$9.83M |
|
38
Beam Therapeutics
BEAM
$1.9B
| $133M | 0.79% |
3,399,921
-231,350
| -6% | -$9.05M |
|
39
Clarivate
CLVT
$2.79B
| $127M | 0.75% |
15,177,433
-25,368,867
| -63% | -$212M |
|
40
Sarepta Therapeutics
SRPT
$1.98B
| $120M | 0.71% |
928,900
+173,950
| +23% | +$22.5M |
|
|
SGFY
41
DELISTED
Signify Health, Inc.
SGFY
| $113M | 0.67% |
3,950,000
+3,600,000
| +1,029% | +$103M |
|
42
Masimo
MASI
$7.43B
| $112M | 0.66% |
758,500
+181,500
| +31% | +$26.9M |
|
|
LHCG
43
DELISTED
LHC Group LLC
LHCG
| $111M | 0.66% |
689,000
+39,000
| +6% | +$6.31M |
|
44
PG&E
PCG
$33.7B
| $83.8M | 0.5% |
5,155,142
-1,150,000
| -18% | -$18.7M |
|
45
KE Holdings
BEKE
$21.8B
| $80.4M | 0.47% |
5,758,500
-4,200,000
| -42% | -$58.6M |
|
|
ONEM
46
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $79M | 0.47% |
4,725,000
+1,800,000
| +62% | +$30.1M |
|
47
Cytokinetics
CYTK
$5.98B
| $78M | 0.46% |
1,701,738
+80,700
| +5% | +$3.7M |
|
48
Lufax Holding
LU
$2.66B
| $74.6M | 0.44% |
9,609,100
+4,475,000
| +87% | +$34.7M |
|
49
Enanta Pharmaceuticals
ENTA
$189M
| $72.1M | 0.43% |
1,550,000
| – | – |
|
50
Tower Semiconductor
TSEM
$6.96B
| $69.8M | 0.41% |
1,615,000
+600,000
| +59% | +$25.9M |
|